The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
about
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic ReviewAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionBiomarker identification in neurologic diseases: improving diagnostics and therapeutics.Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptomsDo antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.The course of brain abnormalities in schizophrenia: can we slow the progression?The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not.Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen.Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk.Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review.Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine TreatmentExtensive gray matter volume reduction in treatment-resistant schizophrenia.Imaging genomics and response to treatment with antipsychotics in schizophrenia.Factors associated with response to clozapine in schizophrenia: a review.Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.Short-term mechanisms influencing volumetric brain dynamics.ADHD and conduct disorder: an MRI study in a community sample.Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.Mitochondria in the striatum of subjects with schizophrenia.Divided attention capacity in adults with autism spectrum disorders and without intellectual disability.Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia.The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users.First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics.Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement
P2860
Q26786253-A2C4F864-ECD8-4A13-B419-A90408CD8E27Q30386608-A708B331-D1D1-4BF0-B484-E9C5371284CAQ33202814-CF991324-352A-49B9-8932-7411C0CDC43DQ33266464-15803BFA-6782-4477-BA95-EF482B2C2FDBQ33425487-E4DEE252-9DCF-4145-B79E-89C1C8AA8C21Q33951370-4058DFBA-5BED-4F3F-BF89-EB455B348CC6Q33985626-A90690AA-E2EB-40A8-8CED-8A8F3B55FE9CQ34034400-F57F2D20-7658-466E-9FC1-ED1FC6380DBAQ34226261-727662AC-76C6-4B68-B6E4-3C352B8CC6EAQ34351095-355AE9F4-C7A2-4910-9CB6-F29AC8FB3017Q34651191-080E69B8-F050-4340-904A-D72F434FD4DFQ34992884-0253B139-0C3F-4FFC-9219-B1903BAF4F79Q35029347-FB7DD085-610D-4350-AEF1-3A3FEA2BD726Q35135220-C38C27F9-B0BE-45FE-BAEE-B10AE7A370B1Q35586017-ECE8CED3-3650-41E1-BC1D-B0F7543382ADQ35960362-B0874E07-7615-413A-921D-1552F6037D0CQ35965893-DDAE73F4-F076-4F71-B180-D050C11C16FCQ36401916-87F7933B-68E0-4FD5-9C12-83059E0ACC15Q37300007-4628730E-0DF3-47C9-BDD5-B700F5EE8DC6Q38762872-2E3F4F8B-0515-481F-80F2-C426684193B4Q42362623-D4A1716E-ABE7-4674-A4D1-A93712D47113Q44271301-ABF7979C-D289-44AC-A1E3-10D812ACD591Q45277253-B31BE5EC-71B2-49B5-94B8-7CE7E13E34D8Q48094326-18FB0C5D-28D0-4BC3-8367-E3FD941BF32FQ48659357-8F3ADD1A-F068-4920-AD0F-2485DACFB42DQ49109228-550C65E8-45BD-4B84-A381-44040A487F57Q49271516-5AE888D3-F6A0-4E8E-BD10-A3699ABDAD4BQ50556051-F2613D81-B687-42D3-8109-3596368CA9FFQ51822628-BF881CF0-564C-478C-BAE4-2AEBD66C1B45Q58701333-D60AB88B-DBBF-449B-A040-69D643E276A9
P2860
The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The effect of clozapine on cau ...... d with typical antipsychotics.
@ast
The effect of clozapine on cau ...... d with typical antipsychotics.
@en
type
label
The effect of clozapine on cau ...... d with typical antipsychotics.
@ast
The effect of clozapine on cau ...... d with typical antipsychotics.
@en
prefLabel
The effect of clozapine on cau ...... d with typical antipsychotics.
@ast
The effect of clozapine on cau ...... d with typical antipsychotics.
@en
P2093
P1476
The effect of clozapine on cau ...... ed with typical antipsychotics
@en
P2093
C C de Wied
F E Scheepers
J A van der Linden
P356
10.1016/S0893-133X(00)00172-X
P407
P577
2001-01-01T00:00:00Z
P6179
1023632005